Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Immunopharmacol ; 100: 108094, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34508942

RESUMO

This work evaluated the immunomodulatory and anti-infective effects of Cratylia mollis lectin (Cramoll) in a model of wound infection induced by S. aureus. Swiss mice were divided into 3 groups (n = 12/group): non-inoculated (Control group); inoculated with S. aureus (Sa group); inoculated with S. aureus and treated with Cramoll (Sa + Cramoll group). In each animal, one lesion (64 mm2) was induced on the back and contaminated with S. aureus (~4.0 × 106 CFU/wound). The treatment with Cramoll (5 µg/animal/day) started 1-day post-infection (dpi) and extended for 10 days. Clinical parameters (wound size, inflammatory aspects, etc.) were daily recorded; while cytokines levels, bacterial load and histological aspects were determined in the cutaneous tissue at 4th dpi or 11th dpi. The mice infected with S. aureus exhibited a delay in wound contraction and the highest inflammatory scores. These effects were impaired by the treatment with Cramoll which reduced the release of key inflammatory mediators (TNF-α, NO, VEGF) and the bacterial load at wound tissue. Histological evaluations showed a restauration of skin structures in the animals treated with Cramoll. Taken together, these results provide more insights about the healing and immunomodulatory properties of Cramoll and suggest this lectin as a lead compound for treatment of wound infection.


Assuntos
Antibacterianos/farmacologia , Fabaceae , Agentes de Imunomodulação/farmacologia , Lectinas de Plantas/farmacologia , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/efeitos dos fármacos , Infecção dos Ferimentos/prevenção & controle , Animais , Antibacterianos/isolamento & purificação , Carga Bacteriana , Modelos Animais de Doenças , Fabaceae/química , Interações Hospedeiro-Patógeno , Agentes de Imunomodulação/isolamento & purificação , Camundongos , Óxido Nítrico/metabolismo , Lectinas de Plantas/isolamento & purificação , Infecções Estafilocócicas/imunologia , Infecções Estafilocócicas/metabolismo , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/crescimento & desenvolvimento , Fator de Necrose Tumoral alfa/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Cicatrização/efeitos dos fármacos , Infecção dos Ferimentos/imunologia , Infecção dos Ferimentos/metabolismo , Infecção dos Ferimentos/microbiologia
2.
Nat Prod Res ; 34(24): 3536-3539, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30870005

RESUMO

The latex of Euphorbia tirucalli L. (LET) has great etnopharmacological relevance for several traditional communities. In this study, the in vitro and in vivo (using Tenebrio molitor larvae) antimicrobial effects of LET were evaluated. LET did not inhibit the growth of S. aureus, however, a reduction on staphyloxanthin production (an important virulence factor of S. aureus) was observed. LET (at 10 µL/kg) was also able to enhance the survival of larvae infected with a lethal dose of S. aureus, an effect associated with reduction in the numbers of haemocytes. Furthermore, haemocytes from LET-treated larvae exhibited dysfunctional lysosome activity. These results indicate the effectiveness of LET as an anti-infective agent which could be useful as source of lead molecules for the development of new therapies against S. aureus-induced infections.


Assuntos
Antibacterianos/farmacologia , Euphorbia/química , Látex/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Tenebrio/microbiologia , Animais , Modelos Animais de Doenças , Hemócitos/efeitos dos fármacos , Larva/efeitos dos fármacos , Larva/microbiologia , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/patogenicidade , Fatores de Virulência/metabolismo , Xantofilas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...